Consistently, pharmacological inhibition of PARP1 rescued decreased HDL-C levels through upregulating hepatic ABCA1 and ApoA-I expressions in AKO mice with WD feeding and attenuated hepatosteatosis. This evidence concerns the gene PARP1 and Wilson disease.